Evidence map›Paper›PMID 41511342›Full record

ReviewCells2025

(TCRαβ

Dimitri Poddighe, Assel Mussayeva, Kuanysh Dossybayeva, Gulsamal Zhubanova, Dinara Galiyeva, Khac Linh Le, Matthew Naanlep Tanko

Abstract readReview
In one paragraph

Review in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dimitri PoddigheCollege of Health Sciences, VinUniversity, Vinhomes Ocean Park, Gia Lam, Hanoi 100000, Vietnam.ORCID 0000-0001-6431-9334
Assel MussayevaSchool of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0009-0003-6666-511X
Kuanysh DossybayevaSchool of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0002-1834-1909
Gulsamal ZhubanovaSchool of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
Dinara GaliyevaSchool of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
Khac Linh LeCollege of Health Sciences, VinUniversity, Vinhomes Ocean Park, Gia Lam, Hanoi 100000, Vietnam.ORCID 0000-0001-9478-9417
Matthew Naanlep TankoSchool of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0003-1270-1886

Funding

Nazarbayev University 20122022CRP1604Science Committee of the Ministry of Higher Education and Science of the Republic of Kazakhstan AP19677323
6 · The paper itself

Abstract

Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease characterized by the destruction of pancreatic β-cells. Both lymphocytes and various innate immune cells contribute to its immunopathogenesis. Among lymphocytes, in addition to CD8

Indexed as

Diabetes Mellitus, Type 1Receptors, Antigen, T-Cell, alpha-betaT-LymphocytesAnimalsHumansReceptors, Antigen, T-Cell, alpha-betaautoimmune diabetesCD4−CD8− T cellsdiabetes mellitus type 1DN T cellsDNT cellsdouble negative T cellsNKT cellsNOD mice

Identifiers

PMID41511342
PMCPMC12786093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.